You are here

Article info

Article menu
Original research
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer
Free

Authors

  1. Correspondence to Professor Giovanni Scambia, Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Roma 00168, Italy; giovanni.scambia{at}policlinicogemelli.it
View Full Text

Citation

Conte C, Marchetti C, Loverro M, et al
Role of minimally invasive secondary cytoreduction in patients with recurrent ovarian cancer
International Journal of Gynecologic Cancer 2023;33:137-144.

Publication history

  • Received August 9, 2022
  • Accepted December 12, 2022
  • First published January 13, 2023.
Online issue publication 
February 06, 2023

Article Versions

  • Supplementary Data

    This web only file has been produced by the BMJ Publishing Group from an electronic file supplied by the author(s) and has not been edited for content.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

Copyright information

© IGCS and ESGO 2023. No commercial re-use. See rights and permissions. Published by BMJ.